Skip to content

World Health Organization Releases Guidelines for Large Multi-Modal Models (LMMs)




The World Health Organization (WHO) recently released guidelines for the ethics and governance of large multi-modal models (LMMs). In the past year, LMMs like Chat GPT have come to the forefront of the news, and people have begun using them in different fields with varying success. Within the healthcare space, LMMs have the potential to respond to patients’ inquiries, identify research topics, and maintain electronic health records. However, the use of LMMs in healthcare raises many legal and ethical questions, such as how they can be used effectively without jeopardizing patient safety and privacy.

On January 18, the WHO released over 40 recommendations for the use of LMMs to promote and protect patient health. In its recommendations, the WHO called for governments to invest in public data sets that require developers and users to adhere to ethical and privacy standards in order to gain access to the data. The WHO also recommends mandatory post-release audits and impact assessments of LMMs to enhance transparency about the model’s accuracy and uncover any biases.

The WHO’s Chief Scientist, Dr. Jeremy Farr, is optimistic that LMMs can “achieve better health outcomes and overcomes persisting health inequities.” But Dr. Farr says these goals can only be reached if “those who develop, regulate, and use these technologies identify and fully account for the associated risks.” Companies like Epic Systems have already begun implementing LMMs into their products, and Dr. Alain Labrique, the WHO Director for Digital Health and Innovation, has called on governments to “lead efforts to effectively regulate the development and use of AI technologies, such as LMMs.”


, , , ,

World Health Organization Releases Guidelines for Large Multi-Modal Models (LMMs) Headshot

Zachary Messick

Zachary Messick’s practice focuses on patent prosecution and portfolio management, due diligence, and patent litigation. Zach currently assists clients in various fields of technology including medical devices, biotechnology, and software.

Zach received his J.D. from the University of Georgia School of Law where he was a member of the Journal of Intellectual Property Law. Before law school Zach attended Clemson University where he received a Bachelor of Science in Bioengineering.

View all posts published by Zachary Messick
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal